MAIA Biotechnology, Inc. (MAIA)

Every figure this model derived for MAIA, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 0 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 28,237,371 AssetsCurrent 2026-06-30
current liabilities 6,257,892 LiabilitiesCurrent 2026-06-30
equity 20,675,010 StockholdersEquity 2026-06-30
interest expense 57 InterestExpense 2024-12-31
revenue 0 Revenues 2024-12-31
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up MAIA on one particular measure came for.

RatioValue
current ratio4.51
current ratio reported4.51
dilution pct44.71

What to be careful about

What this model itself distrusts about MAIA's figures. Written by the derivation as it ran, not added afterwards.